NOVT 📈 Novanta - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: CA67000B1040
NOVT: Laser, Medical, Robotics, Automation, Photonics, Motors, Encoders
Novanta Inc. is a leading global provider of innovative solutions, operating through three distinct segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The company's Precision Medicine and Manufacturing segment delivers photonics-based solutions, including a range of laser products such as CO2 lasers, solid state lasers, and ultrafast lasers, which cater to various industrial and medical applications, including DNA sequencing, medical imaging, and laser procedures. Additionally, this segment offers optical light engine products, serving the needs of industrial processing, metrology, and life science imaging.
The Medical Solutions segment provides a broad portfolio of medical grade technologies, encompassing medical insufflators, pumps, and related disposables, as well as visualization solutions, wireless technologies, and video integration technologies designed for operating room integrations. This segment also offers optical data collection and machine vision technologies, radio frequency identification technologies, thermal chart recorders, spectrometry technologies, and embedded touch screen solutions, all of which contribute to enhanced patient care and improved medical outcomes. By delivering these cutting-edge solutions, Novanta Inc. supports the advancement of medical research, diagnostics, and treatment.
Novanta Inc.'s Robotics and Automation segment is focused on providing innovative solutions for industrial automation, including optical and inductive encoders, precision motors, servo drives, and motion control solutions. The company also offers integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles, all of which are designed to enhance the efficiency, precision, and reliability of industrial processes. With a diverse range of products and solutions, Novanta Inc. serves a broad customer base across various industries, including medical, industrial, and scientific research.
Novanta Inc. markets and sells its products through a combination of direct sales force and distributors, operating under a range of well-established brands, including Cambridge Technology, Synrad, Laser Quantum, and Celera Motion, among others. The company's global presence, combined with its diverse portfolio of innovative solutions, positions it as a leading player in the precision technology industry. With a history dating back to 1968, Novanta Inc. has evolved significantly over the years, adopting its current name in 2016 and continuing to drive growth and innovation in the industries it serves.
As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol NOVT, Novanta Inc. is committed to delivering long-term value to its shareholders, while also contributing to the advancement of various industries through its innovative solutions. With its headquarters located in Bedford, Massachusetts, the company is well-positioned to leverage its global presence, diverse portfolio, and commitment to innovation to drive continued growth and success in the years to come.
Additional Sources for NOVT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NOVT Stock Overview
Market Cap in USD | 5,892m |
Sector | Technology |
Industry | Scientific & Technical Instruments |
GiC Sub-Industry | Electronic Equipment & Instruments |
IPO / Inception | 2016-01-04 |
NOVT Stock Ratings
Growth 5y | 56.4% |
Fundamental | 27.4% |
Dividend | - |
Rel. Strength Industry | -126 |
Analysts | 4/5 |
Fair Price Momentum | 136.45 USD |
Fair Price DCF | 68.49 USD |
NOVT Dividends
No Dividends PaidNOVT Growth Ratios
Growth Correlation 3m | -72.8% |
Growth Correlation 12m | 44.8% |
Growth Correlation 5y | 80% |
CAGR 5y | 11.09% |
CAGR/Mean DD 5y | 0.90 |
Sharpe Ratio 12m | -0.22 |
Alpha | -41.78 |
Beta | 1.32 |
Volatility | 51.87% |
Current Volume | 577.1k |
Average Volume 20d | 215.7k |
As of December 22, 2024, the stock is trading at USD 153.50 with a total of 577,136 shares traded.
Over the past week, the price has changed by -7.64%, over one month by -6.94%, over three months by -12.05% and over the past year by -6.64%.
Neither. Based on ValueRay Fundamental Analyses, Novanta is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 27.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NOVT as of December 2024 is 136.45. This means that NOVT is currently overvalued and has a potential downside of -11.11%.
Novanta has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy NOVT.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NOVT Novanta will be worth about 152.4 in December 2025. The stock is currently trading at 153.50. This means that the stock has a potential downside of -0.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 178 | 16% |
Analysts Target Price | 165.5 | 7.8% |
ValueRay Target Price | 152.4 | -0.7% |